Inmagene Biopharmaceuticals
VerifiedInmagene is a clinical-stage biotech company developing innovative and differentiated therapies for immunological and inflammatory diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$400—600m (Dealroom.co estimates Jun 2021.)
San Diego California (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor | $0.0 | round | |
$100m | Series C | ||
| Total Funding | 000k | ||
Related Content
Recent News about Inmagene Biopharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.